Family Medicine · Saint Clairsville, OH
NPI
1003828849
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
103 Plaza Dr Ste G
Saint Clairsville, OH, 43950
Phone (304) 650-5027
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
2,730 services
Medicare patients, 2024
237
Average age 73
Drug cost, 2024
$271K
7,545 prescriptions
Company payments, 2024
$14.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph J Glorioso was code 99214 (office e&m - established), 697 times for 232 patients. In total Joseph J Glorioso billed 2,730 services in 37 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 697 | 232 | $75.39 | $53K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 544 | 48 | $0.09 | $46.24 |
| 93000 Electrocardiogram | Office | 206 | 194 | $7.89 | $1,626 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 188 | 35 | $0.53 | $100 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 178 | 178 | $114.77 | $20K |
| 96372 Injection Administration | Office | 170 | 69 | $9.35 | $1,590 |
| 82270 Immunoassay | Office | 168 | 168 | $4.29 | $721 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 156 | 32 | $0.33 | $52.19 |
| J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 80 | 31 | $0.02 | $1.44 |
| 99215 Office E&M - Established | Office | 77 | 50 | $116.56 | $8,975 |
| 99213 Office E&M - Established | Office | 74 | 56 | $53.93 | $3,991 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 21 | 21 | $34.45 | $723 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 14 | 14 | $146.65 | $2,053 |
| G0008 Administration of influenza virus vaccine | Office | 12 | 12 | $30.41 | $365 |
| 90756 Vaccine Product | Office | 12 | 12 | $31.72 | $381 |
By year: 2022 $114K for 3,268 services; 2023 $114K for 3,715 services; 2024 $99K for 2,730 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 168 | 168 | $4.29 | $721 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph J Glorioso prescribed most often to Medicare patients was Atorvastatin Calcium, with 480 prescriptions and refills. In total Joseph J Glorioso wrote 7,545 Medicare prescriptions that cost $271K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 480 | 1,178 | 122 | $5,137 |
| Rosuvastatin Calcium Generic | 468 | 1,257 | 131 | $8,833 |
| Levothyroxine Sodium Generic | 368 | 939 | 88 | $3,130 |
| Omeprazole Generic | 332 | 771 | 85 | $2,842 |
| Lisinopril Generic | 317 | 825 | 87 | $2,140 |
| Amlodipine Besylate Generic | 281 | 710 | 67 | $1,240 |
| Hydrochlorothiazide Generic | 256 | 714 | 68 | $999 |
| Meloxicam Generic | 241 | 605 | 83 | $1,408 |
| Simvastatin Generic | 233 | 583 | 57 | $1,826 |
| Ezetimibe Generic | 232 | 611 | 71 | $5,275 |
| Montelukast Sodium Generic | 213 | 482 | 56 | $2,222 |
| Tamsulosin Hcl Generic | 209 | 513 | 63 | $3,120 |
| Pravastatin Sodium Generic | 165 | 411 | 39 | $1,890 |
| Sertraline Hcl Generic | 153 | 391 | 40 | $919 |
| Glipizide Er Glipizide | 139 | 374 | 36 | $2,915 |
Brand drugs: - claims; generic drugs: 6,971 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Joseph J Glorioso $14.18 ($14.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $14.18.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $14.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.